IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
IQVIA announced a strategic collaboration with Medera Inc. to accelerate the development of cardiac gene therapies and human-based drug discovery platforms. The partnership leverages IQVIA’s global clinical trial infrastructure and regulatory expertise to support Medera’s Sardocor gene therapy programs and Novoheart’s mini-Heart tissue platforms.
Key figures
- Countries
- 100
- Employees
- 94000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.